[Seite 51↓]

LITERATURVERZEICHNIS

1. Adelson PD, Kochanek PM. Head injury in children. J. Child Neurol 1998; 13: 2-15

2. Ajayi-Obe M, Saeed N, Cowan FM, Rutherford MA, Edwards AD. Reduced development of cerebral cortex in extremely preterm infants. Lancet 2000; 356: 1162-1163

3. Amato M, Fauchere JC, Hermann U Jr. Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage. Neuropediatrics 1988; 19: 154-157

4. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22: 455-463

5. Barkovich AJ, Truwit LT. Brain damage from perinatal asphyxia: correlation of MR findings with gestational age. Am J Neuroradiol 1990; 11: 1087-1096

6. Battin M, Maalouf EF, Counsell S, Herilhy AH, Edwards AD. Magnetic resonance imaging of the brain of premature infants. Lancet 1997; 349: 1741

7. Becher B, D´Souza SD, Troutt AB, Antel JP. Fas expression on human fetal astrocytes without susceptibility to Fas-mediated cytotoxicity. Neurosci 1998; 84: 627-634

8. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 1999; 27: 62-74

9. Beer R, Franz G, Schopf M, Reindl M, Zelger B, Schmutzhard E, Poewe W, Kampfl A. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 2000; 20: 669-677

10. Berger R, Garnier Y, Jensen A. Perinatal brain damage: underlying mechanisms and neuroprotective strategies. J Soc Gynecol Investig 2002; 9: 319-328

11. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993; 15: 414-443

12. Bittigau P, Pohl D, Sifringer M, Shimizu H, Ikeda M, Stadthaus D, Fuhr S, Dikranian K, Olney JW, Ikonomidou C. Modeling pediatric head trauma: Mechanisms of degeneration and potential strategies for neuroprotection. Restor Neurol Neurosci 1998; 13: 11-23

13. Bittigau P, Sifringer M, Pohl D, Stadthaus D, Ishimaru M, Shimizu H, Ikeda M, Lang D, Speer A, Olney JW, Ikonomidou C. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 1999; 45: 724-735

14. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002; 99: 15089-15094


[Seite 52↓]

15. Braun KP, de Graaf RA, Vandertop WP, Gooskens RH, Tulleken KA, Nicolay K. In vivo 1H MR spectroscopic imaging and diffusion weighted MRI in experimental hydrocephalus. Magn Reson Med 1998; 40: 832-839

16. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, Tuomanen E. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nature Med 1999; 5: 298-302

17. Braun JS, Novak R, Murray PJ, Eischen CM, Susin SA, Kroemer G, Halle A, Weber JR, Tuomanen EI, Cleveland JL. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis 2001; 184: 1300-1309

18. Brisse H, Fallet C, Sebag G, Nessmann C, Blot P, Hassan M. Supratentorial parenchyma in the developing fetal brain: in vitro MR study with histologic comparison. Am J Neuroradiol 1997; 18: 1491-1497

19. Brück Y, Brück W, Kretzschmar HA, Lassmann H. Evidence for neuronal apoptosis in pontosubicular neuron necrosis. Neuropathol Appl Neurobiol 1996; 22: 23-29

20. Chao MV, Bothwell M. Neurotrophins: to cleave or not to cleave. Neuron 2002; 33: 9-12

21. Charlier N, Leclere N, Felderhoff U, Heldt J, Kietzmann T, Obladen M, Gross J. Hypoxia-induced cell death and changes in hypoxia-inducible factor-1 activity in PC12 cells upon exposure to nerve growth factor. Brain Res Mol Brain Res 2002; 104: 21-30

22. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC. Fas/Apo-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci 1999; 19: 1754-1770

23. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762

24. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999

25. Childs AM, Ramenghi LA, Evans DJ. MR features of developing periventricular white matter in preterm infants: evidence of glial cell migration. AJNR 1998; 19: 971-976

26. Clark RS, Kochanek PM, Watkins SC, Chen M, Dixon CE, Seidberg NA, Melick J, Loeffert JE, Nathaniel PD, Jin KL , Graham SH. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 2000; 74: 740-753

27. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 1998; 18: 5663-5672

28. Dammann O, Leviton A. Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention? Pediatrics 1999; 104: 541-550


[Seite 53↓]

29. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Acta Paediatr 2002; 91: 9-13

30. Dechant G, Barde YA. The neurotrophin receptor p75 (NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131-1136

31. Del Bigio MR, Zhang YW. Cell death, axonal damage, and cell birth in the immature rat brain following induction of hydrocephalus. Exp Neurol 1998; 154: 157-169

32. Del Bigio MR, Wilson MJ, Enno T. Chronic hydrocephalus in rats and humans: white matter loss and behavior changes. Ann Neurol 2003; 53: 337-346

33. Diamond PT. Brain injury in the Commonwealth of Virginia: an analysis of Central registry data 1988-1993. Brain Injury 1996; 10: 414-419

34. Dikranian K, Ishimaru MJ, Tenkova T, Labruyere J, Qin YQ, Ikonomidou C, Olney JW. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis 2001; 8: 359-379

35. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79-83

36. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000; 47: 54-63

37. Dowling P, Shang G, Sumul R, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in the multiple sclerosis brain. J Exp Med 1996; 184: 1513-1518

38. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, Hagberg H. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13: 1101-1106

39. Emslie HC, Wardle SP, Sims DG, Chiswick ML, D'Souza SW. Increased survival and deteriorating developmental outcome in 23-25 weeks gestation infants, 1990-1994 compared with 1984-1989. Arch Dis Child Fetal Neonatal Ed 1998; 78: 99-104

40. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, Moskowitz MA. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 1998; 18: 238-247

41. Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, Tanaka M, Trentz O, Nagata S. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. J Neuroimmunol 1997; 80: 93-96

42. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 44: 798-800

43. Fassbender K, Eschenfelder C, Hennerici M. Fas (APO-1/CD95) in inflammatory CNS diseases: intrathecal release in bacterial meningitis. J Neuroimmunol 1999; 93: 122-125

44. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981; 211: 67-77


[Seite 54↓]

45. Felderhoff-Müser U, Taylor DL, Greenwood KG, Stibenz D, Kozma M, Joashi U, Edwards AD, Mehmet H. Fas/CD95/Apo-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol 2000; 10: 19-27

46. Felderhoff-Mueser U, Ikonomidou C. Mechanisms of neurodegeneration after paediatric brain injury. Curr Opin Neurol 2000; 13: 141-145

47. Felderhoff-Mueser U, Bittigau P, Sifringer M, Mahler L, Hoehn T, Ikonomidou C, Obladen M, Bührer C. Expression of cytokines and growth factors in oxygen-induced apoptotic cell death in the developing rat brain. Ped Res 2002; 52: A76

48. Fink K, Zhu J, Namura S, Shimizu-Sasamata M, Endres M, Ma J, Dalkara T, Yuan J, Moskowitz MA. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J Cereb Blood Flow Metab 1998; 18: 1071-1076

49. Friede RL. Ponto-subicular lesions in perinatal anoxia. Arch Pathol 1972; 94: 343-354

50. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003; 348: 1365-1375

51. Galasko D. Biological markers and the treatment of Alzheimer's disease. J Mol Neurosci 2001; 17: 119-125

52. Gillardon F, Kiprianova I, Sandkuhler J, Hossmann HA, Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience 1999; 93: 1219-1222

53. Gilles FH, Averill DR Jr, Kerr CS. Neonatal endotoxin encephalopathy. Ann Neurol 1977; 2: 49-56.

54. Goldstein M. Traumatic brain injury: a silent epidemic. Ann Neurol 1990; 27: 327

55. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997; 11: 135-176

56. Grunau RE, Whitfield MF, Davis C. Pattern of learning disabilities in children with extremely low birth weight and broadly average intelligence. Arch Pediatr Adolesc Med 2002; 156: 615-620

57. Hagberg H, Ichord R, Palmer C, Yager JY, Vannucci SJ. Animal models of developmental brain injury: relevance to human disease. Dev Neurosci 2002; 24: 364-366

58. Hall AS, Young IR, Davies FJ, Mohaparta SN. A dedicated magnetic resonance system in a neonatal intensive therapy unit (In) Bradley WG, Bydder GM (Eds) Advanced MR imaging techniques. London: Martin Dunitz, 1997 S. 281-289

59. Hamrick SEG, Ferriero DM. The injury response in the term newborn brain: can we neuroprotect ? Curr Opin Neurol 2003; 16: 147-154


[Seite 55↓]

60. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-5781

61. Harter L, Keel M, Hentze H, Leist M, Ertel W. Caspase-3 activity is present in cerebrospinal fluid from patients with traumatic brain injury. J Neuroimmunol 2001; 121: 76-78

62. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776

63. Hentze H, Schwoebel F, Lund S, Keel M, Ertel W, Wendel A, Jaattela M, Leist M, Kehl M. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun 2001; 283: 1111-1117

64. Herdegen T, Claret FX, Kallunki T, Martin Villalba A, Winter C, Hunter T, Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 1998; 18: 5124-5135

65. Heyes MP, Saito K, Milstien S, Schiff SJ. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J Neurol Sci 1995 ; 133 : 112-118

66. Himi T, Ishizaki Y, Murota S. A caspase inhibitor blocks ischaemia-induced delayed neuronal death in the gerbil. Eur J Neurosci 1998; 10: 777-781

67. Hoehn T, Felderhoff-Mueser U, Maschewski K, Stadelmann C, Sifringer M, Bittigau P, Koehne P, Hoppenz M, Obladen M, Bührer C. Hyperoxia causes inducible nitric oxide synthase mediated cellular damage to the immature rat brain. 2003; Ped Res (in press)

68. Horwood LJ, Mogridge N, Darlow BA. Cognitive, educational and behavioural outcomes at 7 to 8 years in a national very low birthweight cohort. Arch Dis Child Fetal Neonatl Ed 1998; 79: F12-F20

69. Hüppi PS. Advances in postnatal neuroimaging: relevance to pathogenesis and treatment of brain injury. Clin Perinatol 2002; 29: 827-856

70. Hughes DP, Crispe IN. A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J Exp Med 1995; 182: 1395-1401

71. Ikonomidou C, Qin Y, Labruyere J, Kirby C, Olney JW. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Res 1996; 39: 1020-1027

72. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 1999; 283: 70-74

73. Inder TE, Huppi PS, Warfield S, Kikinis R, Zientara GP, Barnes PD, Jolesz F, Volpe JJ. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 1999; 46: 755-760

74. Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, Olney JW. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 1999; 408: 461-476


[Seite 56↓]

75. James HE. Pediatric head injury: what is unique and different. Acta Neurochir Suppl (Wien) 1999; 73 : 85-88

76. Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Kozma M, Greenwood K, Edwards AD, Mehmet H. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 2000; 11: 1919-32

77. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001; 56: 1278-1284

78. Kadhim H, Tabarki B, Prez CD, Sebire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol (Berl) 2003; 105: 209-216

79. Kato H, Kogure K, Liu X-H, Araki T, Itoyama Y. Progressive expression of immunomolecules on activated microglia and invading leucocytes following focal cerebral ischemia in the rat. Brain Res 1996; 734: 203-212

80. Kayahara M, Felderhoff-Mueser U, Pocock J, Hughes MN, Mehmet H. NO. and NO+ reduce mitochondrial membrane potential and trigger apoptosis in neural PC12 cells. Biochem Soc Trans 1998; 26: S 340

81. Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, Dietrich WD. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab 2001; 21: 1189-1198

82. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257

83. Kirpalani H, Asztalos E. Neonatal brain injury. Curr Opin Pediatr 2001; 13: 227-233

84. Koskiniemi M, Kyykka T, Nybo T, Jarho L. Long-term outcome after severe brain injury in preschoolers is worse than expected. Arch Pediatr Adolesc Med 1995; 149: 249-254

85. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994; 142: 175-191

86. Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71: 163-210

87. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-795

88. Kraus JF, Fife D, Conroy C. Pediatric brain injuries: the nature, clinical course and early outcomes in a defined United States population. Pediatrics 1987; 79: 501-507

89. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997a; 18: 44-51

90. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997b; 3: 614-620


[Seite 57↓]

91. Leib SL, Kim YS, Black SM, Tureen JH, Tauber MG. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 1998; 177: 692-700

92. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. J Neuroimmunol 2002; 122: 167-174

93. Leviton A, Gilles FH. An epidemiologic study of perinatal leucoencephalopathy in an autopsy population. Am J Epidemiol 1976; 104: 621-626

94. Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects. Ment Retard Dev Disabil Res Rev 2002; 8: 46-50

95. Liou JC, Fu WM. Regulation of quantal secretion from developing motoneurons by postsynaptic activity-dependent release of NT-3. J Neurosci 1997; 17: 2459-2468

96. Liu JH, Wei S, Lamy T, Li Y, Epling-Burnette PK, Djeu JY, Loughran TP Jr. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 2002; 100: 1449-1453

97. Lobner D, Ali C. Mechanisms of bFGF and NT-4 potentiation of necrotic neuronal death. Brain Res 2002; 954: 42-50

98. Maalouf E, Counsell S, Battin M, Cowan F. Magnetic resonance imaging of the neonatal brain. BJHM 1998; 59: 41-45

99. Maalouf EF, Duggan PJ, Rutherford MA, Counsell SJ, Fletcher AM, Battin M, Cowan F, Edwards AD. Manetic resonance imaging of the brain in a cohort of extremely preterm infants. J Pediatr 1999; 135: 351-357

100. Maalouf EF, DugganPJ, Counsell SJ, Rutherford MA, Cowan F, Azzopardi D, Edwards AD. Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm infants. Pediatrics 2001; 107: 719-727

101. Mahoney WJ, D´Souza BJ, Haller A, Rogers MC, Epstein MH, Freeman JM. Long-term outcome of children with severe head trauma and prolonged coma. Pediatrics 1983; 1: 756-762

102. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999 19: 3809-3817

103. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001; 8: 659-661

104. Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards CK 3rd, Chaudry IH, Zhang HG, Mountz JD. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells. Cell Death Differ 2002; 9: 626-635


[Seite 58↓]

105. Matsuyama T, Hata R, Yamamoto Y, Tagaya M, Akita H, Uno H, Wanaka A, Furuyama J, Sugita M. Localisation of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridisation. Mol Brain Res 1995; 34: 166-172

106. Mazarakis ND, Edwards AD, Mehmet H. Apoptosis in neural development and disease. Arch Dis Child Fetal Neonatal Ed 1997; 77: F165-170

107. McCallister AK, Katz LC, Lo DC. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 1996; 17: 1057-1064

108. McDonald JW, Stefovska VG, Liu XZ, Shin H, Liu S, Choi DW. Neurotrophin potentiation of iron-induced spinal cord injury. Neuroscience 2002; 115: 931-939

109. Mehmet H, Yue X, Squier MV, Lorek A, Cady E, Penrice J, Sarraf C, Wylezinska M, Kirkbride V, Cooper C, Brown GC, Wyatt JS, Reynolds EOR, Edwards AD. Increased apoptosis in the cingulate sulcus of new-born piglets following transient hypoxia-ischaemia is related to the degree of high energy phosphate depletion during the insult. Neurosci Lett 1994; 181: 121-125

110. Miller SP, Vigneron DB, Henry RG, Bohland MA, Ceppi-Cozzio C, Hoffman C, Newton N, Partridge JC, Ferriero DM, Barkovich AJ. Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging. 2002; 16: 621-632

111. Milligan DW. Failure of autoregulation and intraventricular haemorrhage in preterm infants. Lancet 1980; 1: 896-898

112. Mito T, Kamei A, Takashima S, Becker LE. Clinicopathological study of pontosubicular necrosis. Neuropediatrics 1993; 24: 204-207

113. Morita-Fujimura Y, Fujimura M, Kawase M, Chen SF, Chan PH. Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis. Neurosci Lett 1999; 267: 201-205

114. Mouw G, Zechel JL, Zhou Y, Lust WD, Selman WR, Ratcheson RA. Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia. Metab Brain Dis 2002; 17: 143-151

115. Murahashi H, Azuma H, Zamzami N, Furuya KJ, Ikebuchi K, Yamaguchi M, Yamada Y, Sato N, Fujihara M, Kroemer G, Ikeda H. Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death in the T cell line Jurkat. J Leukoc Biol 2003; 73: 399-406

116. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456

117. Nat R, Radu E, Regalia T, Popescu LM. Apoptosis in human embryo development: Fas-induced apoptosis in brain primary cultures. J Cell Mol Med 2001a; 5: 417-428

118. Nat R, Voiculescu B, Stanciu C, Vidulescu C, Cergan R, Badiu C, Popescu LM. Apoptosis in human embryo development: Cerebellum. J Cell Mol Med 2001b; 5: 179-187

119. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-675


[Seite 59↓]

120. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson PG, Dickens BF, Phillips TM. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53: 600-607

121. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000; 407: 810-816

122. Nishimura T, Akiyama H, Yonehara S, Kondo H, Ikeda K, Kato H, Iseki E, Kosaka K. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 1995; 695: 137-145

123. Northington FJ, Ferriero DM, Flock DL, Martin LJ. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001; 21: 1931-1938

124. Olney JW, Adamo NJ, Ratner A. Monosodium glutamate effects. Science 1971; 172: 294

125. Padosch SA, Popp E, Vogel P, Bottigerr BW. Altered protein expression levels of Fas/CD95 and Fas Ligand in differentially vulnerable brain areas in rats after global cerebral ischemia. Neurosci Lett 2003; 338: 247-251

126. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, Yonehara S. Expression of fas antigen in the normal mouse brain. Biochem Biophys Res Commun 1998; 252: 623-628

127. Peter ME, Krammer PH. Mechanisms of CD95(Apo-1/Fas)-mediated apoptosis. Curr Opi Immunol 1998; 10: 545-551

128. Peter ME, Krammer PH The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26-35

129. Peterson BS, Vohr B, Staib LH, Cannistraci CJ, Dolberg A, Schneider KC, Katz KH, Westerveld M, Sparrow S, Anderson AW, Duncan CC, Makuch RW, Gore JC, Ment LR. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000; 284: 1939-1947

130. Peterson BS, Anderson AW, Ehrenkranz R, Staib LH, Tageldin M, Colson E, Gore JC, Duncan CC, Makuch R, Ment LR. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003; 111: 939-948

131. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hübner C, Olney JW, Turski L, Ikonomidou C. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 1999; 96: 2508-2513

132. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99-104

133. Ouallet J, Baumann N, Marie Y, Villarroya H. Fas system up-regulation in experimental autoimmune encephalomyelitis. J Neurol Sci 1999; 170: 96-104

134. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000; 17: 927-938


[Seite 60↓]

135. Reiss A, Felderhoff-Mueser U, Braun J, Bührer C, Weber J. Bacterial toxins contribute to neuronal damage in pneumococcal neonatal rat meningitis. Ped Res 2002; 52: A203

136. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141

137. Riffkin CD, Gray AZ, Hawkins CJ, Chow CW, Ashley DM. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction. Neuro-oncol 2001; 3: 229-240

138. Roelants-van Rijn AM, Groenendaal F, Beek FJ, Eken P, van Haastert IC, de Vries LS. Parenchymal brain injury in the preterm infant: comparison of cranial ultrasound, MRI and neurodevelopmental outcome. Neuropediatrics 2001; 32: 80-89

139. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 1997; 99: 1173-1178

140. Sabri F, De Milito A, Pirskanen R, Elovaara I, Hagberg L, Cinque P, Price R, Chiodi F. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J Neuroimmunol 2001; 114: 197-206

141. Sibony O, Stempfle N, Luton D, Oury JF, Blot PH. In utero fetal cerebral intraparenchymal ischemia diagnosed by nuclear magnetic resonance. Dev Med Child Neurol 1998; 40: 122-123

142. Silverstein F, Barks J, Hagan P, Liu X, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int 1997; 30: 375-383

143. Skranes JS, Nilsen G, Smevik O, Vik T, Brubakk AM. Cerebral MRI of very low birthweight children at 6 years of age compared with the findings at 1 year. Pediatr Radiol 1998; 28: 471-475

144. Skullerud K, Skjaeraasen J. Clinicopathological study of germinal matrix hemorrhage, pontosubicular necrosis, and periventricular leukomalacia in stillborn. Childs Nerv Syst 1988; 4: 88-91

145. Sonntag J, Grimmer I, Scholz T, Metze B, Wit J, Obladen M. Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis. Acta Paediatr 2000; 89: 528-532

146. Sosin DM, Sniezek JE, Waxweiler RJ. Trends in death associated with traumatic brain injury, 1979 through 1992. Success and failure. JAMA 1995; 273: 1778-1780

147. Stadelmann C, Mews I, Anu Srinivasan, Deckwerth TL, Lassmann H, Brück W. Expression of cell death-associtaed proteins in neuronal apoptosis associated with pontosubicular necrosis. Brain Pathol 2001; 11: 273-281

148. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler, M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446


[Seite 61↓]

149. Szaflarski J, Burtrum D, Silverstein F. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995; 26: 1093-1100

150. Taglialatela G, Perez-Polo JR, Rassin DK. Induction of apoptosis in the CNS during development by the combination of hyperoxia and inhibition of glutathione synthesis. Free Radic Biol Med 1998; 25: 936-942

151. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-1135.

152. Tanaka M, Itai T, Adachi M, Nagata S. Downreglation of Fas ligand by shedding. Nat Med 1998; 1: 31-36

153. Tarkowski E, Rosengren L, Blomstrand C, Jensen C, Ekholm S, Tarkowski A. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 1999; 30: 321-327

154. Tauscher MK, Berg D, Brockmann M, Seidenspinner S, Speer CP, Groneck P. Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates. Biol Neonate 2003; 83: 166-170

155. Taylor DL, Edwards AD, Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol 1999; 9: 93-117

156. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316

157. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil 1999; 14: 602-615

158. Tin W, Wariyar U, Hey E. Changing prognosis for babies of less than 28 weeks gestation in the north of England between 1983 and 1994. Northern Neonatal Network. BMJ 1997; 314: 107-111

159. Tommiska V, Heinomen K, Kero P, Pokela ML, Tammela O, Jarvenpaa AL, Salokorpi T, Virtanen M, Fellman V. A national two year follow up study of extremely low birthweight infants born in 1996-1997. Arch Dis Child Neonatal Ed 2003; 88: F29-F35

160. Towfighi J, Mauger D, Vannucci RC, Vannucci SJ. Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res 1997; 100 : 149-160

161. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-305

162. Troy CM, Friedman JE, Friedman WJ. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J Biol Chem 2002; 277: 34295-34302

163. Vexler ZS , Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol 2001; 6: 99-108

164. Volpe JJ Neurology of the newborn (4. Ausgabe), WB Saunders, Philadelphia 2001, S. 314 ff.


[Seite 62↓]

165. van Landeghem FK, Felderhoff-Mueser U, Moysich A, Stadelmann C, Obladen M, Bruck W, Bührer C. Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis. Pediatr Res 2002; 51: 129-135

166. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306

167. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996; 273: 959-963

168. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AL. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci 1997; 17: 7415-7424

169. Yeh W-C, de la Pompa JL, McCurrach ME, Shu H-B, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279: 1954-1958

170. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, Chi JG. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997; 177: 797-802

171. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407: 802-809

172. Zandbergen EG, de Haan RJ, Hijdra A. Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med 2001; 27: 1661-1667

173. Zhang J, Cado D, Chen A, Kabra NH, Winoto-A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300

174. Zipp F, Weller M, Calabresi PA, Frank JA, Bash CN, Dichgans J, McFarland HF, Martin R. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol 1998; 43: 116-120


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
22.04.2004